Goldman Sachs’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,203
| Closed | -$3.21K | – | 5188 |
|
|
2025
Q1 | $3.21K | Buy |
1,203
+349
| +41% | +$932 | ﹤0.01% | 5033 |
|
|
2024
Q4 | $3.77K | Buy |
+854
| New | +$3.77K | ﹤0.01% | 4970 |
|
|
2023
Q3 | – | Sell |
-752
| Closed | -$25.5K | – | 4787 |
|
|
2023
Q2 | $25.5K | Buy |
+752
| New | +$25.5K | ﹤0.01% | 4736 |
|
|
2022
Q4 | – | Sell |
-258
| Closed | -$19K | – | 5210 |
|
|
2022
Q3 | $19K | Sell |
258
-56
| -18% | -$4.12K | ﹤0.01% | 5180 |
|
|
2022
Q2 | $48K | Buy |
314
+185
| +143% | +$28.3K | ﹤0.01% | 5285 |
|
|
2022
Q1 | $79K | Sell |
129
-105
| -45% | -$64.3K | ﹤0.01% | 5372 |
|
|
2021
Q4 | $293K | Buy |
234
+169
| +260% | +$212K | ﹤0.01% | 4791 |
|
|
2021
Q3 | $182K | Buy |
+65
| New | +$182K | ﹤0.01% | 4897 |
|
|
2017
Q1 | – | Sell |
-22
| Closed | -$112K | – | 4441 |
|
|
2016
Q4 | $112K | Sell |
22
-7
| -24% | -$35.6K | ﹤0.01% | 4074 |
|
|
2016
Q3 | $123K | Sell |
29
-8
| -22% | -$33.9K | ﹤0.01% | 4118 |
|
|
2016
Q2 | $192K | Buy |
37
+32
| +640% | +$166K | ﹤0.01% | 3875 |
|
|
2016
Q1 | $24K | Buy |
5
+2
| +67% | +$9.6K | ﹤0.01% | 4349 |
|
|
2015
Q4 | $16K | Hold |
3
| – | – | ﹤0.01% | 4367 |
|
|
2015
Q3 | $34K | Hold |
3
| – | – | ﹤0.01% | 4404 |
|
|
2015
Q2 | $24K | Hold |
3
| – | – | ﹤0.01% | 4529 |
|
|
2015
Q1 | $42K | Hold |
3
| – | – | ﹤0.01% | 4316 |
|
|
2014
Q4 | $45K | Hold |
3
| – | – | ﹤0.01% | 4402 |
|
|
2014
Q3 | $34K | Hold |
3
| – | – | ﹤0.01% | 4413 |
|
|
2014
Q2 | $54K | Buy |
3
+1
| +50% | +$18K | ﹤0.01% | 4276 |
|
|
2014
Q1 | $30K | Buy |
+2
| New | +$30K | ﹤0.01% | 4269 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 4251 |
|